Bo Dupont - Publications, H-index & Citations

Bo Dupont

centre hospitalier universitaire de caen normandie

95H指数

539论文数

3.5W被引数

收录论文 49

发表时间

Impact of timing of access to endoscopic drainage and social determinants of health on the prognosis of patients with periampullary cancer diagnosed through jaundice: a multicenter retrospective study 通过黄疸诊断的壶腹周围癌患者，内镜引流时机与社会决定因素对其预后的影响：一项多中心回顾性研究

Therapeutic Advances in Gastroenterology

IF3.4

2026-02-27

OAAI

Benoît Dupont; Olivier Dejardin; Wendy Kam; Ludivine Launay; Laurent Mosquet; Romain Gloro; Véronique Bouvier; Marie-Astrid Piquet; Arnaud Alves

Soluble and membrane-bound interleukin (IL)-15 R/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections 可溶性和膜结合白介素 (IL)-15 R/IL-15复合物介导高亲和力中央记忆CD8 T细胞的增殖，用于癌症和感染的过继免疫治疗

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2016-08-31

OAAI

Hasan, A. N.; Selvakumar, A.; Shabrova, E.; Liu, X. -R.; Afridi, F.; Heller, G.; Riviere, I.; Sadelain, M.; Dupont, B.; O'Reilly, R. J.

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I

IMMUNITY

IF26.3

2016-08-01

OAAI

Boudreau, Jeanette E.; Liu, Xiao-Rong; Zhao, Zeguo; Zhang, Aaron; Shultz, Leonard D.; Greiner, Dale L.; Dupont, Bo; Hsu, Katharine C.

Donor Activating KIR2DS1 in Leukemia

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2014-11-20

OAAI

Venstrom, Jeffrey M.; Dupont, Bo; Hsu, Katharine C.

NK Cell Tolerance of Self-Specific Activating Receptor KIR2DS1 in Individuals with Cognate HLA-C2 Ligand

JOURNAL OF IMMUNOLOGY

IF3.4

2013-05-01

OAAI

Pittari, Gianfranco; Liu, Xiao-Rong; Selvakumar, Annamalai; Zhao, Zeguo; Merino, Ernesto; Huse, Morgan; Chewning, Joseph H.; Hsu, Katharine C.; Dupont, Bo

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2012-09-04

199

OAAI

Tarek, Nidale; Le Luduec, Jean-Benoit; Gallagher, Meighan M.; Zheng, Junting; Venstrom, Jeffrey M.; Chamberlain, Elizabeth; Modak, Shakeel; Heller, Glenn; Dupont, Bo; Cheung, Nai-Kong V.; Hsu, Katharine C.

HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2012-08-30

361

OAAI

Venstrom, Jeffrey M.; Pittari, Gianfranco; Gooley, Ted A.; Chewning, Joseph H.; Spellman, Stephen; Haagenson, Michael; Gallagher, Meighan M.; Malkki, Mari; Petersdorf, Effie; Dupont, Bo; Hsu, Katharine C.

Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis

MULTIPLE SCLEROSIS JOURNAL

IF5

2011-12-20

PREAI

Jelcic, Ilijas; Hsu, Katharine C.; Kakalacheva, Kristina; Breiden, Petra; Dupont, Bo; Uhrberg, Markus; Martin, Roland; Muenz, Christian; Luenemann, Jan D.

NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving Anti-GD2 monoclonal antibody 3F8

CANCER RESEARCH

IF16.6

2010-04-01

PREAI

Venstrom, Jeffrey M.; Zheng, Junting; Kushner, Brian H.; Modak, Shakeel; Danis, Karen E.; Cheung, Irene Y.; Dupont, Bo; Cheung, Nai-Kong; Hsu, Katharine C.

KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma

CLINICAL CANCER RESEARCH

IF10.2

2009-11-30

108

OAAI

Venstrom, Jeffrey M.; Zhen, Junting; Noor, Nabila; Danis, Karen E.; Yeh, Alice W.; Cheung, Irene Y.; Dupont, Bo; O'Reilly, Richard J.; Cheung, Nai-Kong V.; Hsu, Katharine C.

A Panel of Artificial APCs Expressing Prevalent HLA Alleles Permits Generation of Cytotoxic T Cells Specific for Both Dominant and Subdominant Viral Epitopes for Adoptive Therapy

JOURNAL OF IMMUNOLOGY

IF3.4

2009-08-15

OAAI

Hasan, Aisha N.; Kollen, Wouter J.; Trivedi, Deepa; Selvakumar, Annamalai; Dupont, Bo; Sadelain, Michel; O'Reilly, Richard J.

The Lytic Potential of Human Liver NK Cells Is Restricted by Their Limited Expression of Inhibitory Killer Ig-Like Receptors

JOURNAL OF IMMUNOLOGY

IF3.4

2009-08-01

OAAI

Burt, Bryan M.; Plitas, George; Zhao, Zeguo; Bamboat, Zubin M.; Nguyen, Hoang M.; Dupont, Bo; DeMatteo, Ronald P.

Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire

CLINICAL CANCER RESEARCH

IF10.2

2009-07-01

OAAI

Bioley, Gilles; Dousset, Christelle; Yeh, Alice; Dupont, Bo; Bhardwaj, Nina; Mears, Gregory; Old, Lloyd J.; Ayyoub, Maha; Valmori, Danila

HLA Class I-Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine

CLINICAL CANCER RESEARCH

IF10.2

2008-12-31

OAAI

Bioley, Gilles; Guillaume, Philippe; Luescher, Immanuel; Yeh, Alice; Dupont, Bo; Bhardwaj, Nina; Mears, Gregory; Old, Lloyd J.; Valmori, Danila; Ayyoub, Maha

Immunology of hematopoietic stem cell transplantation: A brief review of its history

IMMUNOLOGICAL REVIEWS

IF8.3

2008-10-09

PREAI

Dupont, B

Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission

CLINICAL CANCER RESEARCH

IF10.2

2008-05-01

OAAI

Diefenbach, Catherine S. M.; Gnjatic, Sacha; Sabbatini, Paul; Aghajanian, Carol; Hensley, Martee L.; Spriggs, David R.; Iasonos, Alexia; Lee, Helen; Dupont, Bo; Pezzulli, Sandra; Jungbluth, Achim A.; Old, Lloyd J.; Dupont, Jakob

HLA alleles determine differences in human natural killer cell responsiveness and potency HLA等位基因决定人类自然杀伤细胞反应性和效力的差异

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2008-02-26

259

OAAI

Kim, Surl; Sunwoo, John B.; Yang, Liping; Choi, Taewoong; Song, Yun-Jeong; French, Anthony R.; Vlahiotis, Anna; Piccirillo, Jay F.; Cella, Marina; Colonna, Marco; Mohanakumar, Thalachallour; Hsu, Katharine C.; Dupont, Bo; Yokoyama, Wayne M.

Polymorphism and domain variability of human killer cell inhibitory receptors

IMMUNOLOGICAL REVIEWS

IF8.3

2006-04-28

PREAI

Selvakumar, A; Steffens, U; Dupont, B

Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus

PEDIATRIC DIABETES

IF5.6

2005-12-01

OAAI

Felner, EI; Klitz, W; Ham, M; Lazaro, AM; Stastny, P; Dupont, B; White, PC

Killer immunoglobulin-like receptor ligand (KIR-L) mismatched natural killer (NK) cells for relapsed myeloma

JOURNAL OF IMMUNOTHERAPY

IF2.9

2005-11-01

PREAI

van Rhee, F; Shi, J; Szmania, S; Rosen, N; Moreno, A; Walker, R; Dupont, B; Hsu, K; Baxter-Lowe, LA; Campana, D; Barlogie, B; Cottler-Fox, M; Tricot, G

研究方向